Table 1 Characteristics of the study population, by steatosis grade

Male Sex, n (%)

44 (83.0)

20 (95.2)

17 (70.8)

7 (87.5)

0.08

Age, median (IQ range)

51 (43–55)

49 (40–54)

49 (43–57)

52 (44–54)

0.7

BMI, median (IQ range)

26.8 (24.6–28.7)

27.1 (24.9–28.7)

26.1 (24.6–28.7)

26.2 (23.8–29.0)

0.9

Diabetes, n (%)

7 (13.2)

2 (9.5)

5 (20.8)

0 (0)

0.2

Dyslipidemia, n (%)

27 (50.9)

10 (47.6)

14 (58.3)

3 (37.5)

0.5

Hypertension, n (%)

14 (26.4)

3 (14.3)

9 (37.5)

2 (25.0)

0.2

Platelets (×10⁹/ml), median (IQ range)

223 (190–270)

228 (161–261)

222 (186–282)

217 (204–286)

0.5

Albumin (g/l), median (IQ range)

46 (44–48)

46 (44–48)

48 (46–50)

45 (44–47)

0.2

AST (IU/l), median (IQ range)

34 (28–51)

29 (25–50)

32 (27–56)

38 (34–51)

0.4

ALT (IU/l), median (IQ range)

60 (50–83)

54 (44–60)

69 (51–89)

80 (60–114)

0.07

g-GT (IU/l), median (IQ range)

51 (32–99)

72 (39–124)

50.5 (33–81)

30 (26–63)

0.06

Alkaline phosphatase (IU/l), median (IQ range)

118 (70–189)

90 (81–181)

113 (65–187)

182 (113–199)

0.5

Glycemia (mg/dl), median (IQ range)

85 (81–94)

89.5 (85–98)

88.5 (85–91)

0.3

Fasted insulin (mUI/l), median (IQ range)

10.6 (8.1–16.2)

12.2 (10.8–15.0)

14 (12.6–27.4)

0.1

HOMA-IR, median (IQ range)

2.4 (2.0–3.5)

2.7 (2.25–3.70)

3.14 (2.64–6.15)

0.1

Total cholesterol, median (IQ range)

207 (180–229)

203 (187–245)

179 (170–208)

0.3

HDL (mg/dl), median (IQ range)

48 (39–55)

45 (42–49)

46 (43–51)

0.7

LDL (mg/dl), median (IQ range)

136 (107–156)

143 (129–151)

101 (86–106)

0.09

Triglycerides (mg/dl), median (IQ range)

110 (77–147)

154 (97–197)

135 (108–167)

0.1